- Physically and chemically comparable to the mineral matrix of human bone
- One of the most widely used bone substitutes by dental professionals (1)
- Available in a variety of formulations
NuOss natural cancellous and cortical bone matrix is produced by the removal of all organic components from bovine bone. Due to its natural porous structure, NuOss is physically and chemically comparable to the mineralized matrix of human bone. The proprietary manufacturing process of NuOss allows for maintenance of the naturally occurring bone mineral structure, including macroscopic and microscopic structures. Due to this trabecular architecture with interconnecting macro and micro pores, the ingrowth of new bone and associated vascularization at the grafting site is optimized. NuOss may be used with autogenous bone where there is an insufficient quantity of bone to fulfill the needs of the proposed surgical procedure.
- Augmentation or reconstructive treatment of the alveolar ridge
- Filling of infrabony periodontal defects
- Filling of defects after root resection, apicoectomy, and cystectomy
- Filling of extraction sockets to enhance preservation of the alveolar ridge
- Elevation of the maxillary sinus floor
- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)
- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR)
Handling: The structure of NuOss aids in particle hydration and delivery of the product to the defect.
Particle Distribution: NuOss maximizes the distribution of the preferred particle sizing within desired ranges.
Particle Structure and Porosity: NuOss maintains the high porosity and trabecular structure of natural mineralized bone and maximizes the potential for angiogenesis. (2)
Granules: NuOss DS features our best-selling small particle NuOss cancellous granules.
Delivery Syringe: The preloaded NuOss Delivery Syringe makes it easier to hydrate and place the graft material, minimizing preparation time and particulate migration at the surgical site.
Just like NuOss granules, naturally structured NuOss Collagen combines the mineral properties of cancellous particulate with the space maintenance of collagen. This highly manageable combination provides a convenient approach to filling periodontal and maxillofacial defects. With NuOss Collagen products, there is no mixing or loose handling.
- Elevation of the maxillary sinus floor
- Filling of infrabony periodontal defects
- Augmentation or reconstructive treatment of the alveolar ridge
- Filling of defects after root resection, apicoectomy, and cystectomy
- Filling of extraction sockets to enhance preservation of the alveolar ridge
- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)
- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR)
NuOss Collagen: Available in 3 sizes, NuOss Collagen can be easily trimmed to shape the defect. Hydration can be done prior to insertion or once it has been placed.
NuOss Plug: Designed to aid in filling extraction sites to enhance preservation of the alveolar ridge. NuOss Plug is easy to place and prevents particulate migration once placed into the surgical site.
Expansion: Expanding composite material allows for placement in a compressed form. Upon hydration/contact with blood, the material will self-expand to fill the entire defect.
NuOss XC Socket: Preshaped and ready to place directly into the extraction cavity.
NuOss XC Sinus: Upon successful elevation of the sinus membrane, NuOss XC Sinus is placed without pre-hydration, into the sinus cavity.
1. 2019 U.S. Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials; iDATA_USDBGS19_MS (pages 37, 130-131, 133, 152 and 158).
2. Klenke FM, Liu Y, Yuan H, Hunziker EB, Siebenrock KA, Hofstetter W. Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A. 2008 Jun 1;85(3):777-86.